Mylan NV (NASDAQ:MYL)

69.82
Delayed Data
As of Apr 17
 +2.98 / +4.46%
Today’s Change
44.80
Today|||52-Week Range
72.62
+23.85%
Year-to-Date

Today’s Trading

Previous close66.83
Today’s open66.48
Day’s range66.31 - 72.16
Volume19,396,822
Average volume (3 months)6,791,222
Market cap$34.2B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+15.96%
Earnings growth (next 5 years)+11.45%
Revenue growth (last year)+11.45%
P/E ratio30.1
Price/Sales2.71
Price/Book8.05

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-2.94-1.60%
VRTXVertex Pharmaceutica...-3.87-3.00%
PRGOPerrigo Company PLC-0.02-0.01%
ZTSZoetis Inc-0.37-0.78%
Data as of 4:05pm ET, 04/17/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$0.73
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers